Medullary thyroid carcinoma is a malignant tumor, and its survival is assessed at 41% based on 10-year survival, which is not considered high among thyroid cancers.
There are four common types of thyroid cancer: papillary thyroid cancer, follicular thyroid cancer, medullary thyroid cancer, and undifferentiated thyroid cancer. Malignant tumors are not evaluated according to the cure rate, but according to the “10-year survival” roughly, medullary thyroid carcinoma is 41%, which is not considered high survival among thyroid cancers.
Medullary thyroid carcinoma is undifferentiated cancer, and the first choice of radical treatment is surgery. For sporadic medullary thyroid carcinoma with bilateral onset, total thyroidectomy should be performed; for sporadic thyroid carcinoma with unilateral small onset and no clear family history, unilateral lobectomy with isthmus lobe resection can be performed, and at the same time, lymph nodes of the neck should be cleared.
Patients should maintain a happy mood, have a balanced diet, avoid overwork, and undergo regular review.
It should be noted that patients with medullary thyroid cancer can improve the prognosis of the disease through “early detection, early diagnosis and early treatment”, so as to minimize the adverse effects of the disease.